Metraipolis › archive › dc_df84feac449d

Mechanisms of resistance to PARP inhibitors in advanced epithelial ovarian cancer: biological determinants and therapeutic implications — Europe PMC PMID:42819173

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42819173
DOI: 10.3389/fonc.2026.1892991
License (as archived): solo-consultazione
Archived: 2026-10-08T13:22:18.998Z
SHA-256 of the archived text: 34c92f138130411c886894028a7accc0e2171404fa74df4f24ecc095bbc3c4ed
Stable URL of this page: https://metraipolis.com/documento/dc_df84feac449d

How to cite

Mechanisms of resistance to PARP inhibitors in advanced epithelial ovarian cancer: biological determinants and therapeutic implications — Europe PMC PMID:42819173 — Europe PMC (en), https://europepmc.org/article/MED/42819173 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_df84feac449d (Metraipolis archive dc_df84feac449d, sha256 34c92f138130411c886894028a7accc0e2171404fa74df4f24ecc095bbc3c4ed)

BibTeX

@misc{dcdf84feac449d,
  title = {Mechanisms of resistance to PARP inhibitors in advanced epithelial ovarian cancer: biological determinants and therapeutic implications — Europe PMC PMID:42819173},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42819173},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_df84feac449d; sha256 34c92f138130411c886894028a7accc0e2171404fa74df4f24ecc095bbc3c4ed},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42819173. Agents can read the archived copy with the MCP tool read_document.